Variable | n | 180-day mortality | ||
---|---|---|---|---|
 |  | HR | 95 % CI | p |
Age, years | 135 | 1.04 | 1.01–1.07 | 0.005 |
SAPS II, point | 130 | 1.06 | 1.05–1.08 | <0.0001 |
Sex | ||||
 Female | 51 | ref. |  |  |
 Male | 84 | 1.42 | 0.70–2.89 | 0.331 |
Chronic disease | ||||
 No | 49 | ref. |  |  |
 Yes | 86 | 1.81 | 0.85–3.84 | 0.124 |
Pentraxin-3 | ||||
 Low ≤52.4 ng/mL |  | ref. |  |  |
 High >52.4 ng/mL |  | 2.60 | 1.28–5.29 | 0.008 |
Procalcitonin | ||||
 Low ≤7.73 μg/L |  | ref. |  |  |
 High >7.73 μg/L |  | 2.22 | 1.11–4.44 | 0.024 |
C-reactive protein | ||||
 Low ≤222 mg/L |  | ref. |  |  |
 High >222 mg/L |  | 0.44 | 0.22–0.89 | 0.021 |